ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,406 | -12.0% | 58,581 | +12.9% | 0.00% | – |
| Q2 2023 | $402,782 | +93.6% | 51,905 | +33.5% | 0.00% | – |
| Q1 2022 | $208,000 | -60.6% | 38,871 | +8.1% | 0.00% | -100.0% |
| Q4 2021 | $528,000 | -30.5% | 35,950 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $760,000 | +27.3% | 36,352 | +7.6% | 0.00% | 0.0% |
| Q2 2021 | $597,000 | +8.3% | 33,774 | +50.2% | 0.00% | 0.0% |
| Q1 2021 | $551,000 | -25.9% | 22,487 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | +242.9% | 21,992 | +153.2% | 0.00% | – |
| Q3 2020 | $217,000 | -36.4% | 8,684 | -14.1% | 0.00% | -100.0% |
| Q2 2020 | $341,000 | – | 10,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |